title: HDL proteomics: pot of gold or Pandora's box?
abstract: In this issue of the JCI, Vaisar et al. studied the proteome of HDL (see the related article beginning on page 746). They reveal, quite unexpectedly, that HDL is enriched in several proteins involved in the complement cascade, as well as in a variety of protease inhibitors, supporting the concept that HDL plays a role in innate immunity and in the regulation of proteolytic cascades involved in inflammatory and coagulation processes. The protein makeup of HDL also appears to be altered in patients with coronary artery disease. HDL proteomics is in its infancy, and preliminary findings will need to be confirmed using standardized approaches in larger clinical samples. However, this approach promises to better elucidate the relationship of HDL to atherosclerosis and its complications and could eventually help in the development of biomarkers to predict the outcome of interventions that alter HDL levels and functions.
authors.affiliation: Cardiovascular Institute, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, PA 19104-6160, USA. muredach@itmat.gcrc.upenn.edu
authors.forename: Muredach P
authors.initials: MP
authors.lastname: Reilly
authors.forename: Alan R
authors.initials: AR
authors.lastname: Tall
mesh_terms: D008076:Cholesterol, HDL / Q000378:metabolism*; D003324:Coronary Artery Disease / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control; D006801:Humans; D020543:Proteome / Q000378:metabolism*; D040901:Proteomics / Q000379:methods*
chemical_list: D008076:Cholesterol, HDL; D020543:Proteome